Abstract
Enzymes with well recognized high chemo-, regio-, and enantio-selectivity are powerful molecules that can efficiently catalyze the production of a variety of chemicals and pharmaceuticals. Undoubtedly, there is a tremendous need for enzymes as biocatalysts used in green chemistry and pharmacy. However, there are limited successes of the industrial applications of enzymes presently due to their poor suitability for most commercial uses. To enable the enzymatic process to substitute the traditional chemical process, most of the natural enzymes must be tailor-made to improve their properties in vitro such as catalytic activity, stability, or substrate scope. In this review, we will discuss current advances in molecular redesign and construction of new biocatalysts by rational and irrational strategies, especially in conjunction with the computational design for rapidly generating new types of catalytic function. Three aspects for enzyme redesign and construction are presented. First one concerns the improvement of the catalytic performance, such as catalytic efficiency, stability, and optimal pH bias. Second enables the optimization of the substrate profiles. Third focuses on generating the novel biocatalysts by de novo design.
Keywords: Biocatalyst, Enzyme property, Protein engineering, De novo design
Current Organic Chemistry
Title: Molecular Redesign and Construction of New Biocatalysts
Volume: 14 Issue: 14
Author(s): Guangyu Yang, Aixi Bai and Yan Feng
Affiliation:
Keywords: Biocatalyst, Enzyme property, Protein engineering, De novo design
Abstract: Enzymes with well recognized high chemo-, regio-, and enantio-selectivity are powerful molecules that can efficiently catalyze the production of a variety of chemicals and pharmaceuticals. Undoubtedly, there is a tremendous need for enzymes as biocatalysts used in green chemistry and pharmacy. However, there are limited successes of the industrial applications of enzymes presently due to their poor suitability for most commercial uses. To enable the enzymatic process to substitute the traditional chemical process, most of the natural enzymes must be tailor-made to improve their properties in vitro such as catalytic activity, stability, or substrate scope. In this review, we will discuss current advances in molecular redesign and construction of new biocatalysts by rational and irrational strategies, especially in conjunction with the computational design for rapidly generating new types of catalytic function. Three aspects for enzyme redesign and construction are presented. First one concerns the improvement of the catalytic performance, such as catalytic efficiency, stability, and optimal pH bias. Second enables the optimization of the substrate profiles. Third focuses on generating the novel biocatalysts by de novo design.
Export Options
About this article
Cite this article as:
Yang Guangyu, Bai Aixi and Feng Yan, Molecular Redesign and Construction of New Biocatalysts, Current Organic Chemistry 2010; 14 (14) . https://dx.doi.org/10.2174/138527210791616768
DOI https://dx.doi.org/10.2174/138527210791616768 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Cytochrome P450 in Herb-Drug Interactions
Current Pharmacogenomics Concepts for Nano-delivery of Therapeutic Immunomodulatory Agents
Current Bionanotechnology (Discontinued) Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Current Cancer Drug Targets Pharmaceutical Approaches for Optimizing Oral Anti-Inflammatory Delivery Systems
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Antidiabetic Effect of Aqueous Corrigiola telephiifolia in Streptozotocin- Induced Diabetic Rats
The Natural Products Journal Current Drug Design Strategies for Fighting Against Swine Influenza
Current Drug Therapy Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?
Current Medicinal Chemistry Cannabinoid Receptor Antagonists and the Metabolic Syndrome: Novel Promising Therapeutical Approaches
Mini-Reviews in Medicinal Chemistry Naturally Occurring Methyl Salicylate Glycosides
Mini-Reviews in Medicinal Chemistry EGFR(s) in Aging and Carcinogenesis of the Gastrointestinal Tract
Current Protein & Peptide Science Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design Insulin Resistance, Glycemic Control and Adiposity: Key Determinants of Healthy Lifespan
Current Alzheimer Research Tetraplex Binding Molecules as Anti-Cancer Agents
Recent Patents on Anti-Cancer Drug Discovery Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Meet Our Editorial Board Member:
Anti-Cancer Agents in Medicinal Chemistry A Review on Skin Targeted Delivery of Bioactives as Ultradeformable Vesicles: Overcoming the Penetration Problem
Current Drug Targets Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Antimicrobial Effect of Garlic (Allium sativum)
Recent Patents on Anti-Infective Drug Discovery Anti-Inflammatory Iridoids of Botanical Origin
Current Medicinal Chemistry